Ophthalmic Viscosurgical Devices
Ophthalmic Viscosurgical Devices Market by Product (Cohesive, Combined, Dispersive), Application (Cataract Surgery, Glaucoma Surgery, Keratoplasty), End User - Global Forecast 2024-2030
360iResearch Analyst
Want to know more about the ophthalmic viscosurgical devices market or any specific requirement? Ketan helps you find what you're looking for.
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[184 Pages Report] The Ophthalmic Viscosurgical Devices Market size was estimated at USD 648.33 million in 2023 and expected to reach USD 702.86 million in 2024, at a CAGR 8.81% to reach USD 1,171.29 million by 2030.

Ophthalmic viscosurgical devices (OVDs) are sterile, viscoelastic devices that are used in eye surgery, primarily during cataract extraction and intraocular lens implantation, as well as in corneal transplantation surgery, glaucoma filtration, and retinal attachment procedures. These devices have unique viscoelastic properties that enable them to maintain eye tissue separation, stabilize ocular structures, protect endothelial cells, and create space within the eye during surgery. Meanwhile, the rising cases of ophthalmic and ocular diseases have propelled the demand for OVDs. However, the stringent government regulations associated with OVDs and the limited availability of invasive and non-invasive treatment options are significant challenges manufacturers face. Companies are frequently working towards adhering to government regulations and researching biocompatible materials or excretable to remain agile within the global space. Moreover, developing advanced OVDs with improved viscoelastic properties, lower toxicity, and enhanced ease of use during surgery presents potential opportunities for the companies. Additionally, expanding markets in emerging economies due to increasing healthcare infrastructure investments offer new avenues for growth.

Regional Insights

In the Americas, the United States and Canada witnessed significant growth in the OVD market for ophthalmic viscosurgical devices, with a highly developed healthcare system and widespread adoption of cataract and refractive surgeries. Patient preference for minimally invasive procedures drives innovations and usage of premium OVD products in this region. In addition, Latin American countries are progressively adopting modern ophthalmic surgical devices, influenced by gradual improvements in healthcare infrastructure. On the other hand, Europe has a well-established market for OVDs, with a strong emphasis on quality and regulatory compliance alongside robust healthcare systems. The European Union's demand for OVDs aligns with an aging population and high surgical standards, while the Middle Eastern market benefits from rising investments in healthcare facilities and a growing medical tourism industry. Moreover, the Asia Pacific region demonstrates a significant and growing demand for OVDs due to the increasing prevalence of ophthalmic conditions such as cataracts and glaucoma, especially in populous countries such as China and India. Advanced research and development facilities in Japan contribute to innovative OVD formulations, increasing the demand for OVDs.

Ophthalmic Viscosurgical Devices Market
To learn more about this report, request a free PDF copy
Market Dynamics

The market dynamics represent an ever-changing landscape of the Ophthalmic Viscosurgical Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Rising Cases of the Ophthalmic and Ocular Disorders
    • Availability of Well-Equipped Healthcare Infrastructure and Increasing Number of Drugs Approvals
  • Market Restraints
    • Availability of Minimally Invasive and Non-Invasive Treatment Options
  • Market Opportunities
    • Introduction of New Types of Ophthalmic Viscosurgical Devices
    • Ongoing Clinical Consideration of Adhesive for Ophthalmic Viscosurgeries
  • Market Challenges
    • Limited Availability of Skilled Professionals for Ophthalmic Procedures
Market Segmentation Analysis
  • Product: Growing popularity of cohesive and dispersive OVDs due to their versatility and surgical safety

    Ophthalmic viscosurgical devices (OVDs) are pivotal in ocular surgeries, particularly during cataracts and corneal operations. These viscoelastic agents are categorized based on their physical properties and surgical applicability. Cohesive OVDs, known for their high molecular weight and elasticity, maintain a singular mass, facilitating easy removal from the anterior chamber. They are often used to hold space in the eye and manipulate tissues. Dispersive OVDs, with their lower molecular weight and viscosity, provide superior endothelial protection by creating a thin layer that coats the corneal endothelium. This makes them ideal during phacoemulsification, protecting the corneal endothelium from potential damage caused by surgical instruments or lens fragments. Meanwhile, combined OVDs, also known as viscoadaptive OVDs, offer a versatile solution that exhibits properties of both cohesive and dispersive types. They adapt to changes in surgical conditions, providing cohesive properties under low-flow situations while behaving as dispersive OVDs under high-shear conditions. Each type serves a specific purpose, and their application is crucial for the success and safety of ophthalmic procedures.

  • Application: Increasing uses of OVDs in cataract and keratoplasty surgeries offering clear visualizations while ensuring patient’s safety

    Ophthalmic viscosurgical devices (OVDs) are crucial in enhancing safety and improving outcomes in various eye surgeries. In cataract surgery, OVDs are essential for maintaining anterior chamber depth, stabilizing eye structures, and protecting corneal endothelial cells during lens extraction and intraocular lens implantation. These devices provide clear visualization and facilitate the manipulation of tissues. During glaucoma surgery, OVDs help maintain the anterior chamber and prevent flat chamber complications postoperatively. They can also modulate the filtration rate in procedures such as trabeculectomy, preventing postoperative hypotony. In keratoplasty or corneal transplantation, OVDs preserve the corneal endothelium and provide space for surgical maneuvers. They contribute to the ease of donor cornea insertion and positioning, reduce trauma during suturing, and decrease postoperative edema, thereby enhancing the overall success of the procedure.

Market Disruption Analysis

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Ophthalmic Viscosurgical Devices Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Ophthalmic Viscosurgical Devices Market.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Ophthalmic Viscosurgical Devices Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

Value Chain & Critical Path Analysis

The value chain of the Ophthalmic Viscosurgical Devices Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

Pricing Analysis

The pricing analysis comprehensively evaluates how a product or service is priced within the Ophthalmic Viscosurgical Devices Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Ophthalmic Viscosurgical Devices Market.

Technology Analysis

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Ophthalmic Viscosurgical Devices Market.

Patent Analysis

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Ophthalmic Viscosurgical Devices Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

Trade Analysis

The trade analysis of the Ophthalmic Viscosurgical Devices Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

Regulatory Framework Analysis

The regulatory framework analysis for the Ophthalmic Viscosurgical Devices Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Ophthalmic Viscosurgical Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Ophthalmic Viscosurgical Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Coherus is Selling Off Its Ophthalmology Franchise to Sandoz

    Coherus BioSciences, Inc., a biopharmaceutical firm, announced a strategic transaction agreement with Sandoz Group regarding its ophthalmic portfolio, including the significant CIMERLI (ranibizumab-earn), a biosimilar to the widely recognized treatment LUCENTIS. This deal underscores Coherus's commitment to enhancing patient care through innovation, particularly in the ophthalmology space. The company, known for its robust pipeline and expertise in advancing novel immunotherapies, primarily for oncology, is poised to broaden its impact within the ophthalmology market through this agreement. [Published On: 2024-01-23]

  • Rayner Announces Acquisition of Sophi

    Rayner, acquiredThis AG is the Swiss originator and producer of cutting-edge Sophi phacoemulsification systems. This strategic move diversifies. Sophi, an acronym for Swiss Ophthalmology Innovation, epitomizes the epitome of surgical advancement with its mobility-focused design and user-centric features, including a triple pump fluidics system, high-precision Intraocular Pressure regulation, and innovative cable-free energy supply paired with wireless capabilities. Rayner's latest acquisition reflects its consistent dedication to revolutionizing eye care and enhancing ophthalmic surgery outcomes globally. [Published On: 2024-01-16]

  • Bausch + Lomb Launches New Ophthalmic Viscosurgical Devices in the United States

    Bausch + Lomb expanded its suite of ophthalmic solutions with the launch of StableVisc, a novel cohesive ophthalmic viscosurgical device (OVD), and the TotalVisc Viscoelastic System in the United States. These offerings are engineered to deliver exceptional dual-action protection throughout cataract surgery. The distinctive feature of the StableVisc OVD is its ability to consistently hold open the anterior chamber of the eye, thus facilitating the smooth removal and insertion of the intraocular lens. [Published On: 2023-04-25]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Ophthalmic Viscosurgical Devices Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmic Viscosurgical Devices Market, highlighting leading vendors and their innovative profiles. These include Advanced BioMatrix, Advin Health Care, ALBOMED GmbH, Alcon Inc., Amring Pharmaceuticals Inc., Bausch & Lomb Incorporated, Beaver-Visitec International, Inc., Bloomage Biotechnology Corporation Limited, Bohus BioTech AB, Carl Zeiss AG, CIMA Technology, Inc., Contipro a.s., Fidia Farmaceutici S.p.A., Henan Universe Intraocular Lens Research and Manufacture Co., Ltd., Ildong Hyaltech Co., Ltd., Johnson & Johnson Services, Inc., Kewpie Corporation, LG Chem Life Sciences, Lifecore Biomedical, Inc., Maxigen Biotech Inc., Ophtechnics Unlimited, Precision Lens, Rayner Group, SERVImed Industrial S.p.A., and Truviz Ophthalmic.

Ophthalmic Viscosurgical Devices Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Market Segmentation & Coverage

This research report categorizes the Ophthalmic Viscosurgical Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Cohesive
    • Combined
    • Dispersive
  • Application
    • Cataract Surgery
    • Glaucoma Surgery
    • Keratoplasty
  • End User
    • Ambulatory Surgical Center
    • Eye Specialty Clinics
    • Hospitals

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

This research report offers invaluable insights into various crucial aspects of the Ophthalmic Viscosurgical Devices Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Ophthalmic Viscosurgical Devices Market, by Product
  7. Ophthalmic Viscosurgical Devices Market, by Application
  8. Ophthalmic Viscosurgical Devices Market, by End User
  9. Americas Ophthalmic Viscosurgical Devices Market
  10. Asia-Pacific Ophthalmic Viscosurgical Devices Market
  11. Europe, Middle East & Africa Ophthalmic Viscosurgical Devices Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 286]
  16. List of Companies Mentioned [Total: 25]
Understanding the Latest Types of Ophthalmic Viscosurgical Devices
October 25, 2023
Understanding the Latest Types of Ophthalmic Viscosurgical Devices
The demand for ophthalmic surgery has significantly increased with the increasing prevalence of eye diseases such as cataracts, glaucoma, and macular degeneration. Ophthalmic viscosurgical devices (OVDs) have played a vital role in making complex eye surgeries safe and effective. The new types of OVDs on the market have revolutionized the field of ophthalmology. This blog post explores the latest kinds of available OVDs.

Coherent Ophthalmic Viscosurgical Device:

The Coherent OVD offers excellent flexibility, which makes it ideal for cataract surgery. Its features allow it to hang when injected, making it simpler for the surgeon to control. The Coherent OVD ensures that the vitreous remains stable during surgery, promoting better visual outcomes after surgery. Additionally, it minimizes any disturbance during surgical procedures, providing a more stable surgical environment.

DisCoVisc and DuoVisc:

DisCoVisc is efficient for complicated surgical procedures. The device helps maintain the anterior chamber space and provides excellent protection to sensitive ocular tissues. It decreases the levels of endothelial cell loss, which can be significant when dealing with complex procedures. DuoVisc, on the other hand, also provides protection to ocular tissues, and its effectiveness with homogenous dispersion of the OVD allows it to be ideal for various surgical procedures such as cataract surgery.


Orthovisc is the latest type of OVD gaining popularity. It vastly differs from other types of OVDs since it is hyaluronic acid-based and used to treat the knee. It is FDA-approved for use by patients with knee osteoarthritis symptoms unresolved by traditional treatments. Orthovisc contains sodium hyaluronate, which is compatible with joint fluid, as it closely emulates the structural composition of the natural lubricating fluid of the knee. It is beneficial in treating arthritic painful conditions and improves mobility.


Healon OVD mimics the natural fluids in the eye to keep ideal space. It helps to protect the endothelial from any physical damage, making it ideal for surgical procedures such as trabeculectomies and cataracts. Furthermore, it is exceptional in maintaining the corneal endothelium's physiological area during and after surgery, significantly improving postoperative outcomes.


Viscoat is an OVD that is a combination of two OVDs, Viscoat and Provisc. It is used in surgical procedures to provide the benefits of both devices. It offers excellent cellular protection, making it ideal during cataract surgery, trabeculectomies, and other surgical procedures. Viscoat increases the wound healing rate, decreases any corneal endothelial cell loss, and maintains the anterior chamber under stable pressure.

The introduction of new types of OVDs into the market has significantly revolutionized ophthalmology. These devices have made complex surgical procedures safer and more effective, with better visual outcomes and postoperative care. Surgeons must select an OVD based on the patient's needs and specific surgical procedures. Choosing a device that offers maximum protection for ocular tissues while providing stability during the surgical procedure is advisable. As technology advances and research continues, the world looks forward to more innovative and effective OVDs.

Frequently Asked Questions
  1. How big is the Ophthalmic Viscosurgical Devices Market?
    Ans. The Global Ophthalmic Viscosurgical Devices Market size was estimated at USD 648.33 million in 2023 and expected to reach USD 702.86 million in 2024.
  2. What is the Ophthalmic Viscosurgical Devices Market growth?
    Ans. The Global Ophthalmic Viscosurgical Devices Market to grow USD 1,171.29 million by 2030, at a CAGR of 8.81%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.